{"id":"CHEMBL101683","canonicalSmiles":"O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1","inchiKey":"GGPZCOONYBPZEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL101683","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07288"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1083185","canonicalSmiles":"COc1cc2c(cc1Cl)C(c1cccc(Br)c1)=NCC2","inchiKey":"IKGXHBGCVQTQBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1083185","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL112687","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1","inchiKey":"QCXJEYYXVJIFCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEDOBEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acedoben","NSC-4002","P-acetamidobenzoic acid"],"crossReferences":{"PubChem":["144207528","170466207","17388806","85148691"],"Wikipedia":["Acedoben"],"drugbank":["DB04500"],"chEBI":["46171"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160160","canonicalSmiles":"O=C1OC2(c3cc(I)c(O)c(I)c3Oc3c2cc(I)c(O)c3I)c2c(Cl)c(Cl)c(Cl)c(Cl)c21","inchiKey":"IICCLYANAQEHCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSE BENGAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rose Bengal Sodium","Rose bengal"],"crossReferences":{"DrugCentral":["4637"],"PubChem":["29218013"],"Wikipedia":["Rose_bengal"],"drugbank":["DB14214"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1186581","canonicalSmiles":"Cc1ccc(-c2cc([C@@H]3C4CCC(C[C@@H]3c3ccc(Cl)cc3)N4C)on2)cc1","inchiKey":"AUXUFNHAVGIVDC-DXTSEPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RTI-336","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RTI 336","RTI 4229-336","Rti-336"],"childChemblIds":["CHEMBL470690"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1200342","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"HYRKAAMZBDSJFJ-LFDBJOOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARAMETHASONE ACETATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Haldrone"],"synonyms":["Dillar","Paramethasone","Paramethasone 21-acetate","Paramethasone acetate"],"crossReferences":{"PubChem":["144206683"],"drugbank":["DB14657"],"chEBI":["31963"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200479","canonicalSmiles":"CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1.Cl","inchiKey":"GUBNMFJOJGDCEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICYCLOMINE HYDROCHLORIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1123","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bentyl","Bentyl preservative free","Dicyclomine Hydrochloride (Preservative-Free)","Dicyclomine hydrochloride","Dicyclomine hydrochloride (preservative free)","Merbentyl","Merbentyl 20"],"synonyms":["Bentylol","Dicyclomine hcl","Dicyclomine hydrochloride","Dicycloverine hydrochloride","Kolantyl hydrochloride","NSC-404381","Wyovin"],"crossReferences":{"DailyMed":["dicyclomine%20hydrochloride"],"PubChem":["26747501","26747502","50106212","50106213","50106214","56423126","855865"],"chEBI":["4515"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950 and is indicated for irritable bowel syndrome."}
{"id":"CHEMBL1200807","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC","inchiKey":"ISHXLNHNDMZNMC-VTKCIJPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORELGESTROMIN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evra","Ortho evra"],"synonyms":["Deacetylnorgestimate","Norelgestromin","RWJ-10553"],"crossReferences":{"DailyMed":["norelgestromin"],"PubChem":["144206200"],"Wikipedia":["Norelgestromin"]},"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0000764","HP_0100608","EFO_0002950"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 investigational indications."}
{"id":"CHEMBL1200843","canonicalSmiles":"CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"NOFOWWRHEPHDCY-DAUURJMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLERGONOVINE MALEATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201356","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methergine","Methylergonovine maleate"],"synonyms":["Methylergometrine maleate","Methylergonovine maleate","Methylergonovinium bimaleate","NSC-757104"],"crossReferences":{"DailyMed":["methylergonovine%20maleate"],"PubChem":["93576602"]},"linkedTargets":{"rows":["ENSG00000135914","ENSG00000184845"],"count":2},"linkedDiseases":{"rows":["MP_0001914"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for hemorrhage."}
{"id":"CHEMBL1201121","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](N3C(=O)[C@@H](c4ccccc4)NC3(C)C)C(=O)N2[C@H]1C(=O)[O-].[K+]","inchiKey":"QRSPJBLLJXVPDD-XFAPPKAWSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"HETACILLIN POTASSIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201116","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Versapen-k"],"synonyms":["Hetacillin potassium","Hetacillin potassium salt","Hetacin-k","NSC-757046","Natacillin","Potassium hetacillin","Versatrex"],"crossReferences":{"chEBI":["34789"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201319","canonicalSmiles":"C[C@H](N)[C@H](O)c1cccc(O)c1","inchiKey":"WXFIGDLSSYIKKV-RCOVLWMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METARAMINOL","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Metaraminol"],"crossReferences":{"Wikipedia":["Metaraminol"],"drugbank":["DB00610"],"chEBI":["6794"]},"childChemblIds":["CHEMBL2062262","CHEMBL4303541","CHEMBL3184244","CHEMBL2062343"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000668","EFO_0005251"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL1201465","drugType":"Unknown","blackBoxWarning":false,"name":"CHYMOTRYPSIN","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alpha chymar","Catarase","Chymar","Chymoral","Chymoral fte","Deanase dc","Zolyse","Zonulysin"],"synonyms":[".alpha.-chymotrypsin","Chymotrypsin"],"crossReferences":{"DrugCentral":["5040"]},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1959 and has 1 investigational indication."}
{"id":"CHEMBL1201629","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN PURIFIED BEEF","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Regular iletin ii"],"synonyms":["Insulin (beef)","Insulin purified beef"],"crossReferences":{"DrugCentral":["5192"]},"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1980 and is indicated for diabetes mellitus."}
{"id":"CHEMBL1201752","canonicalSmiles":"C/C(=C\\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1","inchiKey":"FABUFPQFXZVHFB-PVYNADRNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IXABEPILONE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ixempra","Ixempra kit"],"synonyms":["Azaepothilone b","BMS 247550-01","BMS-247550","BMS-247550-01","Ixabepilone","Ixempra","NSC-747973"],"crossReferences":{"Wikipedia":["Ixabepilone"],"drugbank":["DB04845"],"chEBI":["63605"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0002938","MONDO_0015686","EFO_0000756","EFO_0000681","MONDO_0004192","EFO_1000231","MONDO_0007254","EFO_0003871","EFO_1001465","EFO_1001469","MONDO_0002087","EFO_0000305","MONDO_0020654","MONDO_0001187","EFO_1001951","EFO_0000565","EFO_0000309","EFO_1001952","MONDO_0002158","EFO_0006352","EFO_1001974","MONDO_0008903","EFO_0000673","EFO_0002499","EFO_0002914","EFO_0000616","EFO_0002618","EFO_0003897","EFO_0006859","MONDO_0008170","EFO_0000349","EFO_0000403","EFO_1001968","EFO_0007535","MONDO_0004986","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001967","MONDO_0044787","EFO_0003032","EFO_0006861","EFO_1000238","MONDO_0011962","EFO_0000574","EFO_1000613","MONDO_0018906","MONDO_0044926"],"count":50},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 5 approved and 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1214192","canonicalSmiles":"CCC1(C)CC(=O)NC(=O)C1","inchiKey":"ORRZGUBHBVWWOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEMEGRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Megimide"],"synonyms":["Bemegride","Megibal","Methetharimide","NSC-58187"],"crossReferences":{"PubChem":["11112173","144203903"],"Wikipedia":["Bemegride"],"drugbank":["DB13740"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1232207","canonicalSmiles":"NC(=O)CC[C@@H](N)C(=O)O","inchiKey":"ZDXPYRJPNDTMRX-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232207","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111226","144205600","170465304","26756688"],"drugbank":["DB02174"],"chEBI":["17061"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233316","canonicalSmiles":"N[C@H]1C(C(=O)O)=CC=C[C@@H]1O","inchiKey":"XBTXTLKLSHACSS-WDSKDSINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233316","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02124"],"chEBI":["60844"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233584","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)O","inchiKey":"AGPKZVBTJJNPAG-WHFBIAKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOLEUCINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 4675","Isoleucine","L-isoleucine","NSC-46708"],"crossReferences":{"drugbank":["DB00167"],"chEBI":["17191"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL123440","canonicalSmiles":"C=CCN(C(=O)c1cc(Cl)cc(OCCCONC(=N)N)c1)C1CCCC1","inchiKey":"XWIUMAPBZWNFNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123440","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06859"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237024","drugType":"Cell","blackBoxWarning":false,"name":"SIPULEUCEL-T","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Provenge"],"synonyms":["APC-8015","APC8015","Sipuleucel-t"],"crossReferences":{"Wikipedia":["Sipuleucel-T"]},"linkedTargets":{"rows":["ENSG00000014257"],"count":1},"linkedDiseases":{"rows":["EFO_0000196","EFO_0000673","MONDO_0008315"],"count":3},"description":"Cell drug with a maximum clinical trial phase of IV (across all indications) and is indicated for prostate cancer and has 2 investigational indications."}
{"id":"CHEMBL1256815","canonicalSmiles":"N#Cc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12","inchiKey":"LZLXHGFNOWILIY-APPDUMDISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADOFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pradofloxacin","Veraflox"],"crossReferences":{"drugbank":["DB11453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1303","canonicalSmiles":"CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1","inchiKey":"KFQYTPMOWPVWEJ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROTIGOTINE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neupro"],"synonyms":["Leganto","Rotigotine","SPM 962","SPM-962"],"crossReferences":{"DailyMed":["rotigotine"],"PubChem":["144206180","170465204","50113269"],"Wikipedia":["Rotigotine"],"drugbank":["DB05271"]},"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0005687","MONDO_0005180","EFO_0000712","MONDO_0004975","EFO_0004270","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for restless legs syndrome and parkinson disease and has 3 investigational indications."}
{"id":"CHEMBL1345","canonicalSmiles":"N=C(N)NCCN1CCCCCCC1.O=S(=O)(O)O","inchiKey":"YUFWAVFNITUSHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANETHIDINE MONOSULFATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL765","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ganda","Guanethidine monosulfate","Ismelin","Ismeline","Lotens"],"synonyms":["Guanethidine monosulfate","Guanethidine monosulphate"],"crossReferences":{"PubChem":["26748068"],"chEBI":["51016"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1489254","canonicalSmiles":"CC(=O)OCC(COC(C)=O)OC(C)=O","inchiKey":"URAYPUMNDPQOKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIACETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Eastman triacetin","Enzactin"],"synonyms":["E-1518","E1518","Estol 1581","FEMA NO. 2007","Glyceryl triacetate","Glyceryltriacetate","Ins no.1518","Ins-1518","NSC-4796","Triacetin","Ujostabil"],"crossReferences":{"PubChem":["144204706","144208943","144210431","170465543","17388686","26747385","26753075","56462778"],"Wikipedia":["Triacetin"],"chEBI":["9661"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1547","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1","inchiKey":"JZRWCGZRTZMZEH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaxin","Vitamin B 1"],"synonyms":["Thiamine"],"crossReferences":{"DailyMed":["thiamine%20hydrochloride"],"Wikipedia":["Thiamine"],"drugbank":["DB00152"],"chEBI":["18385"]},"childChemblIds":["CHEMBL1200941","CHEMBL1588","CHEMBL2104496"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 approved and 11 investigational indications."}
{"id":"CHEMBL1595","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"RBOXVHNMENFORY-DNJOTXNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROCODEINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[".alpha.-hydrocodol","8,14-dihydroneopine","Codhydrine","Dehacodin","Dh-codeine","Dihydrocodeine","IDS-ND-008(SECT.2)","NSC-231319","Novicondin","Rapacodin","Remedacen"],"crossReferences":{"DailyMed":["dihydrocodeine%20bitartrate"],"Wikipedia":["Dihydrocodeine"],"drugbank":["DB01551"]},"childChemblIds":["CHEMBL2062266"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for pain."}
{"id":"CHEMBL1614650","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](N)CC3","inchiKey":"ZVYVPGLRVWUPMP-FYSMJZIKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXATECAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DX-8951","Exatecan"],"crossReferences":{"Wikipedia":["Exatecan"],"drugbank":["DB12185"]},"childChemblIds":["CHEMBL3989759"],"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002618","EFO_0000616","MONDO_0008170","MONDO_0007254","MONDO_0002087","MONDO_0008315","EFO_0000565","MONDO_0002691","MONDO_0002158","MONDO_0002974","MONDO_0008903","EFO_0000574","EFO_0000691","EFO_1000158"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL16503","canonicalSmiles":"O=C(O)CCCCCCCNC(=O)c1ccccc1O","inchiKey":"NJEKDCUDSORUJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALCAPROZIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Salcaprozic acid"],"childChemblIds":["CHEMBL2107027"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1693","canonicalSmiles":"CCN(CC)C(C)C(=O)c1ccccc1.Cl","inchiKey":"ICFXZZFWRWNZMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLPROPION HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1194666","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apisate","Diethylpropion hydrochloride","Tenuate","Tenuate dospan","Tepanil","Tepanil ten-tab"],"synonyms":["Amfepramone hydrochloride","Anorex","D03801","Diethylpropion HCl","Diethylpropion hcl","Diethylpropion hydrochloride","Diethylpropion hydrochloride civ","Dobesin","Moderatan","Prefamone","Regenon"],"crossReferences":{"DailyMed":["diethylpropion%20hydrochloride"],"PubChem":["170464650"],"chEBI":["643703"]},"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0000676","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for obesity."}
{"id":"CHEMBL1725","canonicalSmiles":"COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I","inchiKey":"DGAIEPBNLOQYER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOPROMIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultravist","Ultravist (pharmacy bulk)","Ultravist 150","Ultravist 240","Ultravist 300","Ultravist 370"],"synonyms":["Iopromide","Proscope","ZK 35760","ZK-35760"],"crossReferences":{"PubChem":["170465023","56463063"],"Wikipedia":["Iopromide"],"drugbank":["DB09156"],"chEBI":["63578"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1742984","drugType":"Antibody","blackBoxWarning":false,"name":"AMATUXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amatuximab","MORAb-009"],"linkedTargets":{"rows":["ENSG00000102854"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000588","EFO_0000770","EFO_0000311"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743012","drugType":"Antibody","blackBoxWarning":false,"name":"ENOKIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7F3COM-2H2","7f3com2h2","Enokizumab","MEDI 528","MEDI-528"],"linkedTargets":{"rows":["ENSG00000145839"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL182","canonicalSmiles":"Nc1nc(O)c2ncn(COC(CO)CO)c2n1","inchiKey":"IRSCQMHQWWYFCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GANCICLOVIR","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cymevene","Cytovene","Ganciclovir","Ganzyk-rtu","Virgan","Vitrasert","Zirgan"],"synonyms":["BW 759U","BW-759U","Cymevene","Ganciclovir","Gancyclovir","NSC-759656","RS-21592","Valganciclovir hydrochloride impurity a"],"crossReferences":{"DailyMed":["ganciclovir"],"PubChem":["11111224","11111225","144203711","170464961","50106328","50113251","56424026","8139883","90341439"],"Wikipedia":["Ganciclovir"],"drugbank":["DB01004"],"chEBI":["465284"]},"childChemblIds":["CHEMBL1200850"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 7 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL184410","canonicalSmiles":"OCc1ccc(Br)cc1","inchiKey":"VEDDBHYQWFOITD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL184410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02822"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189607","canonicalSmiles":"Nc1nc2ccc(C(=O)c3c(F)cccc3F)cn2c1C(=O)c1ccccc1","inchiKey":"WUGJIPFLBOATGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL189607","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL191275","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)Oc1ccc(-c2ccccc2)cc1","inchiKey":"TZTPJJNNACUQQR-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191275","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08121"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19236","canonicalSmiles":"COc1nc(C)nc(Cl)c1NC1=NCCN1","inchiKey":"WPNJAUFVNXKLIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXONIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cynt","Fisiotens","Norcynt","Normatens","Nucynt","Physiotens"],"synonyms":["BDF-5896","BDF5896","BE-5895","BE5895","LY-326869","LY326869","Moxonidine"],"crossReferences":{"PubChem":["11111430","11111431","144203741","170466534","85148350","90341434"],"Wikipedia":["Moxonidine"],"drugbank":["DB09242"],"chEBI":["7009"]},"childChemblIds":["CHEMBL1256287"],"linkedTargets":{"rows":["ENSG00000010322"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0003777","EFO_0000275","EFO_0000401","EFO_0005252","EFO_0000618","EFO_0001073","EFO_0000660","EFO_0000537"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL1950649","canonicalSmiles":"CCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)nc(C#CC[C@H]4CC[C@H](C(=O)OC)CC4)nc32)[C@H](O)[C@@H]1O","inchiKey":"FLEVIENZILQUKB-XTWQNQIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APADENOSON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stedivaze"],"synonyms":["Apadenoson","BMS-068645","BMS068645","Bms-068645"],"crossReferences":{"drugbank":["DB05009"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1964546","canonicalSmiles":"Nc1ccc2cc3ccc(N)cc3nc2c1.O=S(=O)(O)O","inchiKey":"WSFHCKWLECYVBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROFLAVINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL55400","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-1510","Proflavin sulfate","Proflavine sulfate","Proflavine sulphate"],"crossReferences":{"PubChem":["522182","72090"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2003538","canonicalSmiles":"CCCCCCCCCCCCCCCC[n+]1ccccc1.O.[Cl-]","inchiKey":"NFCRBQADEGXVDL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CETYLPYRIDINIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL305906","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceepryn","Cepacol","Gppe dental rinse","Gppe oral liq","Merocet","Merocets","Merocets plus","Merovit","Search","Steradent"],"synonyms":["Cetylpyridinium chloride","Cetylpyridinium chloride hydrate","Cetylpyridinium chloride monohydrate","NB-002","NSC-14864","NSC-756673"],"crossReferences":{"PubChem":["103076120"],"chEBI":["3566"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL200377","canonicalSmiles":"O=C(O)c1ccc(-c2ccccc2C(F)(F)F)o1","inchiKey":"IJPNRBZMRINMMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["845165"],"drugbank":["DB07759"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2027925","canonicalSmiles":"Nc1c(Cl)cc(-c2nn(C3CCN(CCc4ccccc4)CC3)c(=O)o2)c2c1OCCO2","inchiKey":"MDBNTXARNGRHEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPESEROD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Capeserod","SL650155","Sl65.0155"],"childChemblIds":["CHEMBL2022742"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2104907","canonicalSmiles":"CCNC1=NC(=O)C(c2ccccc2)O1","inchiKey":"RXOIEVSUURELPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOZOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenozolone","LD 3394","LD-3394","Phenozolone"],"crossReferences":{"drugbank":["DB13341"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104957","canonicalSmiles":"CC(C)(C)CC(C)(C)c1cc(Cc2cc(C(C)(C)CC(C)(C)C)cc(-n3nc4ccccc4n3)c2O)c(O)c(-n2nc3ccccc3n2)c1","inchiKey":"FQUNFJULCYSSOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISOCTRIZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tinosorb m"],"synonyms":["Bisoctrizole","FAT 75'634","FAT-75634","MBBT","NSC-759873"],"crossReferences":{"PubChem":["144206094","225144291"],"drugbank":["DB11262"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105606","canonicalSmiles":"CCCC(=O)C1=C(O)C(C)(C)C(O)=C(Cc2c(OC)cc(O)c(C(=O)CCC)c2O)C1=O","inchiKey":"GAHOBHHMYUYJDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESASPIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desaspidin","Desaspidin bb"],"crossReferences":{"drugbank":["DB13567"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107767","canonicalSmiles":"FC(F)(F)c1cccc(C2=CCN(CCc3ccc(-c4ccccc4)cc3)CC2)c1","inchiKey":"CNEWKIDCGDXBDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALIRODEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Paliroden","SR5-7667B","SR57667B","Sr57667b"],"crossReferences":{"drugbank":["DB05454"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108041","drugType":"Antibody","blackBoxWarning":false,"name":"OCRELIZUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ocrevus"],"synonyms":["2H7","Ocrelizumab","PR-070769","PR070769","R-1594","RG-1594"],"crossReferences":{"DailyMed":["ocrelizumab"]},"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0003840","MONDO_0005301","EFO_0008520","EFO_0002690","EFO_0003929","EFO_0007332","EFO_0005952","EFO_0000540","EFO_0008522"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 5 approved and 4 investigational indications."}
{"id":"CHEMBL2108085","drugType":"Protein","blackBoxWarning":false,"name":"SULGLICOTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Demucine","Gliptide","Sulglicotide","Sulglycotide"],"crossReferences":{"DrugCentral":["4725"]},"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108185","drugType":"Protein","blackBoxWarning":false,"name":"CORIFOLLITROPIN ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elonva"],"synonyms":["Corifollitropin alfa","MK-8962","ORG 36286","ORG-36286","SCH 900962","SCH-900962"],"linkedTargets":{"rows":["ENSG00000170820"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0001073","MONDO_0018555"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108591","drugType":"Antibody","blackBoxWarning":false,"name":"ELSILIMOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["B-e8"],"synonyms":["Elsilimomab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108921","drugType":"Unknown","blackBoxWarning":false,"name":"CHOCOLATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cacao minar whole","Cacao whole","Chocolate","Theobroma cacao","Theobroma cacao whole","Theobroma caribaea whole","Theobroma integerrima whole","Theobroma kalagua whole","Theobroma saltzmanniana whole"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109284","drugType":"Antibody","blackBoxWarning":false,"name":"CMB-401","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CMB-401","HCTMO1-CALICHEAMICIN"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109423","drugType":"Antibody","blackBoxWarning":false,"name":"MAB-3F8","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MAB-3F8","Mab-3f8"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109642","drugType":"Antibody","blackBoxWarning":false,"name":"A33 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A33","A33 131i"],"linkedTargets":{"rows":["ENSG00000143167"],"count":1},"linkedDiseases":{"rows":["EFO_1001951"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110618","canonicalSmiles":"CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(C(=O)OC[C@H](COC(=O)N(Cc2cccc[n+]2CC)C(=O)c2ccccc2OC)OC)CC1","inchiKey":"HGOAIWZFTWACBD-RRHRGVEJSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"MINOPAFANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-5880","Minopafant"],"childChemblIds":["CHEMBL2104419"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110938","canonicalSmiles":"OC(c1ccccc1)(c1ccccc1)C1CCCCN1","inchiKey":"XSWHNYGMWWVAIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPRADROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-pipradol","Gerodyl","MRD-108","Pipradol","Pipradrol","Pipralon","Piridrol","Pyridrol","Pyridrole"],"crossReferences":{"drugbank":["DB11584"]},"childChemblIds":["CHEMBL2106720"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL21333","canonicalSmiles":"O=C(Nc1cccc2c(=O)cc(-c3nn[nH]n3)oc12)c1ccc(OCCCCc2ccccc2)cc1","inchiKey":"NBQKINXMPLXUET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRANLUKAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azlaire","CCN 00401","CCN-00401","ONO 1078","ONO-1078","Pranlukast","RS 411","RS-411","SB 205312","SB-205312"],"crossReferences":{"PubChem":["144206505"],"Wikipedia":["Pranlukast"],"drugbank":["DB01411"]},"childChemblIds":["CHEMBL3810125"],"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["HP_0006536","EFO_0007486","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL216981","canonicalSmiles":"CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1","inchiKey":"RXIUEIPPLAFSDF-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAVARIXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-7123","Navarixin","PS-291822","PS291822","SCH-527123","SCH527123"],"childChemblIds":["CHEMBL2103864"],"linkedTargets":{"rows":["ENSG00000180871","ENSG00000163464"],"count":2},"linkedDiseases":{"rows":["EFO_0000676","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2181666","canonicalSmiles":"[18F]c1ccc([P+](c2ccccc2)(c2ccccc2)c2ccccc2)cc1","inchiKey":"QWPLCHDPESWJRN-FNNGWQQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BFPET F-18","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2221306","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18f-tpp","4-(18f)-tetraphenylphosphonium","4-[18F]Fluorophenyl)Triphenylphosphonium","Bfpet f-18"],"crossReferences":{"drugbank":["DB15424"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL228057","canonicalSmiles":"O=C(O)[C@H]1O[C@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"HDYANYHVCAPMJV-LXQIFKJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Uridine-5'-Diphosphoglucuronic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uridine-5'-Diphosphoglucuronic Acid"],"crossReferences":{"drugbank":["DB03041"],"chEBI":["17200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2315212","canonicalSmiles":"CCCC(CCC)C(=O)[O-].CCCC(CCC)C(=O)[O-].[Mg+2]","inchiKey":"LKLLHOIUJVEAGU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM VALPROATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL109","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Magnesium valproate"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL231884","canonicalSmiles":"COc1ccc(-c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2)cc1O","inchiKey":"GZSOSUNBTXMUFQ-YFAPSIMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOSMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diovenor"],"synonyms":["Barosmin","Buchu resin","Daflon","Diosmetin 7-rutinoside","Diosmin","Diosven","Dioven","Flebaven","Flebavena","Flebosmil","Flebosten","Hemerven","Hesperidin","Insuven","Litosmil","NSC-758417","Tovene","Varinon","Ven-detrex","Venosmine"],"crossReferences":{"PubChem":["144204945","170466258","50085952"],"Wikipedia":["Diosmin"],"drugbank":["DB08995"],"chEBI":["4631"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL2364612","canonicalSmiles":"O=C(CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1)OCCCCO[N+](=O)[O-]","inchiKey":"LOVMMUBRQUFEAH-UIEAZXIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATANOPROSTENE BUNOD","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vesneo","Vyzulta"],"synonyms":["BOL-303259-X","Bol-303259-x","Latanoprostene bunod","NCX 116","NCX-116","PF-3187207"],"crossReferences":{"DailyMed":["latanoprostene%20bunod"],"drugbank":["DB11660"]},"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved indications."}
{"id":"CHEMBL240725","canonicalSmiles":"Cc1c(S(=O)(=O)c2ccc(=O)[nH]n2)oc2ccc(Cl)cc12","inchiKey":"FXFPQPNUMWQRAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL240725","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07187"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260046","canonicalSmiles":"Cn1c(COP(=O)(NCCBr)NCCBr)cnc1[N+](=O)[O-]","inchiKey":"UGJWRPJDTDGERK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVOFOSFAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evofosfamide","HAP-302","TH-302"],"crossReferences":{"drugbank":["DB06091"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL266497","canonicalSmiles":"O=C1NC(=O)[C@@]2(CCOc3ccc(F)cc32)N1","inchiKey":"LXANPKRCLVQAOG-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORBINIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-45,634","CP-45634","NSC-355082","Sorbinil"],"crossReferences":{"PubChem":["144205232","170466611","29215399"],"drugbank":["DB02712"],"chEBI":["102029"]},"linkedTargets":{"rows":["ENSG00000085662"],"count":1},"linkedDiseases":{"rows":["EFO_0003770"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL269538","canonicalSmiles":"COc1ccc2c(c1)[nH]c1c(C)nccc12","inchiKey":"BXNJHAXVSOCGBA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HARMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Harmine"],"crossReferences":{"PubChem":["11112332","118045984","124360166","124882255","124882257","124882258","124882259","26748430","26753728","26753729","50107399","85239699"],"Wikipedia":["Harmine"],"drugbank":["DB07919"],"chEBI":["28121"]},"childChemblIds":["CHEMBL486818","CHEMBL1593867"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270687","canonicalSmiles":"CCCOc1ccnc2[nH]cc(-c3ccnc(N)n3)c12","inchiKey":"ZHMRPXZRUZLCNL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERIOLIN 5","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08182"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL271227","canonicalSmiles":"CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC=C(c5cccnc5)[C@@]4(C)CC[C@@H]32)C1","inchiKey":"UVIQSJCZCSLXRZ-UBUQANBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABIRATERONE ACETATE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yonsa","Zytiga"],"synonyms":["Abiraterone acetate","CB-7630","CB7630","NSC-748121","NSC-749227"],"crossReferences":{"DailyMed":["abiraterone%20acetate"],"PubChem":["144207138"],"chEBI":["68639"]},"linkedTargets":{"rows":["ENSG00000148795"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","MONDO_0008315","EFO_0003060","EFO_0001663","Orphanet_418","EFO_0000311","EFO_0003826","HP_0000083","Orphanet_90794","EFO_0001421","EFO_1000499","EFO_0000673","EFO_0000196","MONDO_0024880"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 6 approved and 7 investigational indications."}
{"id":"CHEMBL272690","canonicalSmiles":"CC(C)C(=O)COc1nc(N)nc2nc[nH]c12","inchiKey":"BEXUQVHWMLPYKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL272690","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03663"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292963","canonicalSmiles":"O=C1C[C@@]2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1ccc(F)cc12","inchiKey":"BMHZAHGTGIZZCT-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Minalrestat","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Minalrestat"],"crossReferences":{"drugbank":["DB07450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039594","canonicalSmiles":"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.O=S(=O)(O)O","inchiKey":"RDEIXVOBVLKYNT-VQBXQJRRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GENTAMICIN SULFATE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039597","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apogen","Bristagen","Cidomycin","Cidomycin intrathecal","Garamycin","Genoptic","Gentacidin","Gentafair","Gentak","Gentamicin sulfate","Genticin","Genticin intrathecal","Lugacin","Septopal","U-gencin"],"synonyms":["Garasol","Gent-ak","Gent-ophtal","Gentacin","Gentalline","Gentalyn","Gentamicin (as sulfate)","Gentamicin (as sulphate)","Gentamicin (gentamycin sulfate)","Gentamicin c complex sulfate","Gentamicin sulfate","Gentamicin sulfate (salt)","Gentamicin sulphate","Gentamicin sulphate (salt)","Gentamicini sulfas","Gentibioptal","Gentocin","Gentogram","NSC-757042","NSC-82261","Ophtagram","Pangram","Refobacin","SCH 9724","SCH-9724","Sulmycin"],"crossReferences":{"DailyMed":["gentamicin%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 7 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL304253","canonicalSmiles":"Cc1ccc(N=C2NCCN2)c(Cl)c1","inchiKey":"KWBTZIFLQYYPTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLONIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST 375","ST-375","Tolonidine"],"crossReferences":{"drugbank":["DB13429"]},"childChemblIds":["CHEMBL3275012"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL306380","canonicalSmiles":"Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1","inchiKey":"ZVPDNRVYHLRXLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL306380","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103904783","17402282","26756734","26756735"],"drugbank":["DB01809"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3085436","canonicalSmiles":"NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@H]([C@H]2C[C@H](O)NC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O","inchiKey":"GXFAIFRPOKBQRV-GHXCTMGLSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VIOMYCIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Celiomycin","Florimycin","Tuberactinomycin b","Vinacetin a","Vioactane","Viomycin"],"crossReferences":{"drugbank":["DB06827"],"chEBI":["15782"]},"childChemblIds":["CHEMBL3989823"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3137328","canonicalSmiles":"N[C@H](CCC(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)[O-])C(=O)[O-].[H+].[K+]","inchiKey":"JBUWHGCMOSDECA-LOCPCMAASA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ORILOTIMOD POTASSIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3137306","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APO-805K1","Apo805K1","Orilotimod potassium"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3184143","canonicalSmiles":"N=C(N)NCC1COC2(CCCCC2)O1.N=C(N)NCC1COC2(CCCCC2)O1.O=S(=O)(O)O","inchiKey":"RTEVGQJRTFFMLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANADREL SULFATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1037","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hylorel"],"synonyms":["CL-1388R","Guanadrel sulfate","Guanadrel sulphate","NSC-760062","U-28,288D","U-28288D"],"crossReferences":{"PubChem":["144204146"],"chEBI":["5556"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL3218576","canonicalSmiles":"COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21","inchiKey":"PZBCKZWLPGJMAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COPANLISIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAY 80-6946","BAY-80-6946","BAY80-6946","Bay-80-6946","Copanlisib"],"crossReferences":{"DailyMed":["copanlisib%20dihydrochloride"],"drugbank":["DB12483"]},"childChemblIds":["CHEMBL3545068"],"linkedTargets":{"rows":["ENSG00000171608","ENSG00000121879"],"count":2},"linkedDiseases":{"rows":["EFO_0005232","MONDO_0044887","MONDO_0007254","EFO_1001469","EFO_0005952","MONDO_0021063","EFO_0002426","EFO_0000305","HP_0000083","EFO_0000096","EFO_1000242","EFO_0000183","EFO_0004606","EFO_0000707","EFO_0000616","MONDO_0019465","EFO_0000220","EFO_0000403","MONDO_0008315","EFO_0003060","EFO_0005221","EFO_0000304","EFO_0000095","EFO_1000238","EFO_0000574","EFO_1001051","MONDO_0018906","MONDO_0024880","EFO_1000233"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 20 investigational indications."}
{"id":"CHEMBL323799","canonicalSmiles":"O=C1NC(=O)[C@@]2(N1)O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O","inchiKey":"HVXIMXHBUJADCC-GTBMBKLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOHYDANTOCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphohydantocidin"],"crossReferences":{"drugbank":["DB02493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301678","canonicalSmiles":"CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC.CCCCCCCC(=O)OCC(O)CO.CCCCCCCCCC(=O)OCC(O)CO.OCC(O)CO","inchiKey":"YTORMSBGFMQNEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOCTANOIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3304484","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moctanin"],"synonyms":["Capmul 8210","Monoctanoin","Monooctanoin"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL3330650","canonicalSmiles":"O=C(NOCCO)c1ccc2cncn2c1Nc1ccc(I)cc1F","inchiKey":"RFWVETIZUQEJEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11982"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3359265","canonicalSmiles":"Cc1nc2ccc(C(=O)N3CCC4(CC3)CC(=O)c3c(cnn3C(C)C)C4)cc2[nH]1","inchiKey":"BDXXSFOJPYSYOC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05175157","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-05175157"],"crossReferences":{"drugbank":["DB12096"]},"linkedTargets":{"rows":["ENSG00000278540","ENSG00000076555"],"count":2},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0003894"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544940","drugType":"Small molecule","blackBoxWarning":false,"name":"G1T28-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G1t28-1"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544946","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06291874","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06291874","Pf-06291874"],"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545119","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-794833","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-794833"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545123","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2cc([C@H]3CC[C@H](c4cc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC)[nH]c5cc4F)N3c3cc(F)c(N4CCC(c5ccc(F)cc5)CC4)c(F)c3)c(F)cc2[nH]1)[C@@H](C)OC","inchiKey":"VJYSBPDEJWLKKJ-NLIMODCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIBRENTASVIR","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A-1325912.0","ABT-530","Pibrentasvir"],"crossReferences":{"DailyMed":["pibrentasvir"],"drugbank":["DB13878"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for chronic hepatitis c virus infection and has 4 investigational indications."}
{"id":"CHEMBL3545275","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2623091","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ly-2623091","Ly2623091"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["MONDO_0001134","EFO_0003884"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545392","drugType":"Small molecule","blackBoxWarning":false,"name":"MT-3995","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apararenone","MT-3995","Mt-3995"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","EFO_1001249"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3623004","canonicalSmiles":"C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F","inchiKey":"DFBDRVGWBHBJNR-BBNFHIFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-9496","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD9496","Azd 9496","Azd-9496","Azd9496"],"crossReferences":{"drugbank":["DB15138"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL362558","canonicalSmiles":"O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2","inchiKey":"HRJWTAWVFDCTGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2090314","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2090314","LY2090314","Ly 2090314","Ly-2090314"],"crossReferences":{"PubChem":["103905564"],"drugbank":["DB11913"]},"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0002618","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL365795","canonicalSmiles":"CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1","inchiKey":"GUHPRPJDBZHYCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIAPROFENIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surgam 200","Surgam 300","Surgam sa"],"synonyms":["RU 15060","RU-15060","Surgam","Tiaprofen","Tiaprofenate","Tiaprofenic acid"],"crossReferences":{"PubChem":["144204178","170465577","56463054"],"Wikipedia":["Tiaprofenic_acid"],"drugbank":["DB01600"],"chEBI":["32221"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL3707278","drugType":"Antibody","blackBoxWarning":false,"name":"CROTEDUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crotedumab","REGN-1193","REGN1193"],"linkedTargets":{"rows":["ENSG00000215644"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL378104","canonicalSmiles":"COc1cc(O)cc(O)c1C(=O)/C=C/c1ccccc1","inchiKey":"NYSZJNUIVUBQMM-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARDAMOMIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cardamomin","Cardamonin"],"crossReferences":{"PubChem":["24841437"],"Wikipedia":["Cardamomin"],"drugbank":["DB14122"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3785197","canonicalSmiles":"CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2ncc(OCCCC(=O)O)cn2)C[C@H]1CC","inchiKey":"NRWORBQAOQVYBJ-GJZUVCINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBICETRAPIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-899","DEZ-001","Obicetrapib","TA-8995","Ta-8995"],"crossReferences":{"drugbank":["DB14890"]},"linkedTargets":{"rows":["ENSG00000087237"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975","EFO_0000319","Orphanet_309005"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL398110","canonicalSmiles":"CCCn1cnc(C[C@H](CCCN)C(=O)O)c1","inchiKey":"OTDGPKRCQXSTPV-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UK-396,082","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UK 396082","UK-396082","Uk-396,082"],"crossReferences":{"drugbank":["DB12099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL398428","canonicalSmiles":"CC(C)Oc1cccc(NC(=O)c2cc(Cl)c(OCCN)c(Cl)c2)c1","inchiKey":"AYKUIRSGEMLIFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL398428","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08072"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3990038","drugType":"Antibody","blackBoxWarning":false,"name":"FLOTETUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flotetuzumab","MGD-006","MGD006","RES-234","RES234","S-80880","S80880"],"linkedTargets":{"rows":["ENSG00000185291","ENSG00000167286","ENSG00000198851","ENSG00000160654"],"count":4},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL405821","canonicalSmiles":"NC(=O)C(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1","inchiKey":"SCTZUZTYRMOMKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SENICAPOC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ICA-17043","PF-05416266","Senicapoc"],"crossReferences":{"drugbank":["DB06280"]},"linkedTargets":{"rows":["ENSG00000104783"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","MONDO_0100096","Orphanet_3202","Orphanet_232","EFO_0010638","MONDO_0004979"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4101807","canonicalSmiles":"CC(C)n1nccc1-c1ncccc1COc1cccc(O)c1C=O","inchiKey":"FWCVZAQENIZVMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOXELOTOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxbryta"],"synonyms":["GBT-440","GBT440","GTX-011","Gbt440","Voxelotor"],"crossReferences":{"DailyMed":["voxelotor"],"drugbank":["DB14975"]},"linkedTargets":{"rows":["ENSG00000244734","ENSG00000188536","ENSG00000206172"],"count":3},"linkedDiseases":{"rows":["EFO_0004610","EFO_0003086","Orphanet_232","EFO_0000768","EFO_0001421"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for sickle cell anemia and has 3 investigational indications."}
{"id":"CHEMBL411879","canonicalSmiles":"C/C1=C/C(=O)O[C@@H]2C[C@@H](CC[C@H](C)/C=C\\CC1)O[C@@](O)([C@@H]1CSC(=O)N1)C2","inchiKey":"NSHPHXHGRHSMIK-JRIKCGFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATRUNCULIN B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-339663"],"crossReferences":{"drugbank":["DB08080"],"chEBI":["49703"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL413965","canonicalSmiles":"O=C(O)Cc1ccc(-c2ccccc2)cc1","inchiKey":"QRZAKQDHEVVFRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FELBINAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolinac","Flexfree","Napageln","Target","Traxam"],"synonyms":["CL 83,544","CL-83544","Felbinac","Felbinac ethyl","L-141","LJC 10,141","LJC-10141","Ly-61017","NSC-16284"],"crossReferences":{"PubChem":["11112568","144204100","170465835","855761"],"Wikipedia":["Felbinac"],"drugbank":["DB07477"],"chEBI":["31597"]},"childChemblIds":["CHEMBL141152"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for arthralgia and myalgia and has 4 investigational indications."}
{"id":"CHEMBL420671","canonicalSmiles":"CCOC(=O)N1CCC(Nc2cc(C)ccn2)CC1","inchiKey":"LNRMJBWADUSJTA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL420671","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297181","canonicalSmiles":"CO[C@@H](C)Cn1c(=O)n(C)c2cnc3ccc(-c4cncc(C(C)(C)O)c4)cc3c21","inchiKey":"ACCFLVVUVBJNGT-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMOTOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY 3023414","LY-3023414","LY3023414","Ly-3023414","Samotolisib"],"crossReferences":{"drugbank":["DB12167"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000588","EFO_0002517","MONDO_0011962","EFO_0004142","MONDO_0007254","EFO_0005952","MONDO_0024880","EFO_0003060","MONDO_0008315","EFO_0009708"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL4297182","canonicalSmiles":"COCCN1C(=O)O[C@@]2(C[C@H]3O[C@]2(C)n2c4ccccc4c4c5c(c6c7ccccc7n3c6c42)C(=O)NC5)C1=O","inchiKey":"SHWPFRVVBIKGAT-LYWBODIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEGCANTRATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-327","CT327","Ct-327","Pegcantratinib","SNA-120","Sna-120"],"linkedTargets":{"rows":["ENSG00000198400"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_1001494","EFO_0000676","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297254","canonicalSmiles":"CS(=O)(=O)O.N=C(NCCCCc1ccc(OCC(O)CO)cc1)NC(=O)c1nc(Cl)c(N)nc1N","inchiKey":"ZYOATBKPEFZNGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"552-02","maximumClinicalTrialPhase":2,"parentId":"CHEMBL212432","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["552-02","PS-552-02"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297257","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)CCN1C(=O)C=CC1=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O","inchiKey":"DJIGFNCGXOAXOW-WTPNCWHFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ALBUVIRTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albuvirtide","FB-006M","Labuvirtide"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297427","canonicalSmiles":"O[C@@]1(c2ncccn2)C[C@@H]2CC[C@H](C1)N2C(c1ccccc1Cl)c1ccccc1Cl","inchiKey":"MQWMHMZNBGQNMT-XHNJZIHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCH-486757","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH 486757","SCH486757","Sch 486757","Sch-486757"],"crossReferences":{"drugbank":["DB12782"]},"linkedTargets":{"rows":["ENSG00000125510"],"count":1},"linkedDiseases":{"rows":["HP_0012735"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297572","drugType":"Unknown","blackBoxWarning":false,"name":"ABBV-3373","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-3373","Abbv-3373"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297580","drugType":"Antibody","blackBoxWarning":false,"name":"ETOKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANB-020","ANB020","Anb020","Etokimab"],"linkedTargets":{"rows":["ENSG00000137033"],"count":1},"linkedDiseases":{"rows":["EFO_0007486","EFO_0007425","MONDO_0004979","EFO_0000274"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297591","canonicalSmiles":"Nc1c(-c2cc(Cc3ccc(COc4ccccn4)cc3)no2)ccc[n+]1COP(=O)([O-])O","inchiKey":"JQONJQKKVAHONF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSMANOGEPIX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APX001","Apx-001","Apx001","E1211","Fosmanogepix"],"crossReferences":{"drugbank":["DB15183"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297667","canonicalSmiles":"NC(=O)NCCC[C@H](N)C(=O)O.O=C(O)CC(O)C(=O)O","inchiKey":"DROVUXYZTXCEBX-WCCKRBBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITRULLINE MALATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL444814","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citrulline malate","Citrulline malate (salt)","L-citrulline dl-malate","L-citrulline malate","Stimol"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297705","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986178","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-ox40 antibody bms-986178","BMS-986178","Bms 986178","Bms-986178"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297712","drugType":"Unknown","blackBoxWarning":false,"name":"C16G2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C16G2","C16g2","STAMP C16G2"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297729","drugType":"Antibody","blackBoxWarning":false,"name":"COSIBELIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK-301","Ck-301","Cosibelimab","TG-1501","Tg-1501"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297742","drugType":"Unknown","blackBoxWarning":false,"name":"DIAMMONIUM GLYCYRRHIZINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diammonium glycyrrhizate","Diammonium glycyrrhizinate"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298136","drugType":"Unknown","blackBoxWarning":false,"name":"AR-177","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR177","Ar-177","T-30177","Zintevir"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298197","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VUPANORSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKCEA-ANGPTL3-LRx","ISIS 703802","ISIS-703802","Vupanorsen"],"linkedTargets":{"rows":["ENSG00000141505","ENSG00000132855"],"count":2},"linkedDiseases":{"rows":["Orphanet_391665","Orphanet_98306"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL439044","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"GTYWGUNQAMYZPF-QPLNMOKZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL439044","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13798"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL442687","canonicalSmiles":"O=c1oc2cc(O)ccc2s1","inchiKey":"SLYPOVJCSQHITR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOXOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-758240","Thioxolone","Tioxolone"],"crossReferences":{"PubChem":["144204937","174006774","26748702","56322573","93576641"],"Wikipedia":["Tioxolone"],"drugbank":["DB13343"],"chEBI":["568021"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL448","canonicalSmiles":"CCCC(C)C1(CC)C(=O)NC(=O)NC1=O","inchiKey":"WEXRUCMBJFQVBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOBARBITAL","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Nembutal"],"synonyms":["Mebubarbital","Mebumal","NSC-28708","Pentobarbital","Pentobarbital calcium","Pentobarbital cii","Pentobarbitone"],"crossReferences":{"DailyMed":["pentobarbital%20sodium"],"PubChem":["144205108","26750091"],"Wikipedia":["Pentobarbital"],"drugbank":["DB00312"],"chEBI":["7983"]},"childChemblIds":["CHEMBL971"],"linkedTargets":{"rows":["ENSG00000145864","ENSG00000166206","ENSG00000163288"],"count":3},"linkedDiseases":{"rows":["EFO_0008526","EFO_0003777","EFO_0003890","MONDO_0043510","EFO_0004698"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and is indicated for insomnia and has 4 investigational indications. It was withdrawn in Norway  in 1980 due to Misuse."}
{"id":"CHEMBL4594315","drugType":"Gene","blackBoxWarning":false,"name":"TIMREPIGENE EMPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AAV2-REP1","Aav2-rep1","NSR-REP1","Timrepigene emparvovec"],"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594453","canonicalSmiles":"CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C.N[C@@H](CC(=O)O)C(=O)O","inchiKey":"CCIDLBRRXVNEDK-KJTVYDLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENOFOVIR DISOPROXIL ASPARTATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1538","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bis-poc-pmpa aspartate","CKD-390","Ckd-390","Gs 4331 aspartate","Tenofovir disoproxil aspartate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594584","drugType":"Unknown","blackBoxWarning":false,"name":"ANTIHEMOPHILIC FACTOR, PEGYLATED (MW 20000) HUMAN SEQUENCE RECOMBINANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adynovate","Adynovi","Antihemophilic factor, pegylated (mw 20000) human sequence recombinant","Pegylated recombinant factor viii","Pegylated rfviii","Rurioctocog alfa pegol"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650434","drugType":"Antibody","blackBoxWarning":false,"name":"ENIBARCIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adrecizumab","Enibarcimab","HAM-8101","HAM8101"],"linkedTargets":{"rows":["ENSG00000148926"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0006834","EFO_0003144"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL478381","canonicalSmiles":"N[C@@H](CCC(=O)Nc1ccc(OCc2ccccc2)cc1)C(=O)O","inchiKey":"BYSBXIPCDJNEBG-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485259","canonicalSmiles":"CC12CCC(CC1)C(C)(C)O2","inchiKey":"WEEGYLXZBRQIMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EUCALYPTOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,8-cineol","1,8-cineole","Cajeputol","Cineole","Eucaly","Eucalyptol","Eucalyptole","Eucapur","Eukalyptol","FEMA NO. 2465","NSC-6171","P-cineole","Terpan"],"crossReferences":{"PubChem":["144204712","144209288","144213219","170465483","17389880","47193678","72164"],"Wikipedia":["Eucalyptol"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL485659","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O","inchiKey":"APGDTXUMTIZLCJ-CGVGKPPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE HEMISUCCINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-759137","Prednisolone hemisuccinate","Prednisolone hydrogen succinate","Prednisolone succinate"],"crossReferences":{"PubChem":["144206954"],"drugbank":["DB14633"]},"childChemblIds":["CHEMBL1412530"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL496634","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCCC(=O)O","inchiKey":"YUFFSWGQGVEMMI-JLNKQSITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCOSAPENTAENOIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Docosapentaenoic acid"],"crossReferences":{"PubChem":["26754943","26754944"],"chEBI":["53488"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL519827","canonicalSmiles":"CCOC(=O)c1c(C)nn(-c2ccccc2Cl)c1C","inchiKey":"XQCKNCFQOJFQFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL519827","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03807"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL522038","canonicalSmiles":"CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(/C(N)=N\\O)cc1)C1CCCCC1","inchiKey":"ZXIBCJHYVWYIKI-PZJWPPBQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XIMELAGATRAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Worldwide"],"year":2006},"tradeNames":["Exanta (proposed)"],"synonyms":["Exanta","H 376/95","Ximelagatran"],"crossReferences":{"PubChem":["144207182"],"Wikipedia":["Ximelagatran"],"drugbank":["DB04898"],"chEBI":["65172"]},"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0000275","HP_0004419"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for recurrent thrombophlebitis and has 2 investigational indications. It was withdrawn in Worldwide  in 2006."}
{"id":"CHEMBL553025","canonicalSmiles":"CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2","inchiKey":"GBABOYUKABKIAF-IELIFDKJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINORELBINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"crossReferences":{"PubChem":["124893200","29217724","50111727"],"drugbank":["DB00361"],"chEBI":["480999"]},"childChemblIds":["CHEMBL538943"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_1000172","MONDO_0009348","EFO_0003869","EFO_0004708","MONDO_0015686","MONDO_0021117","EFO_0000571","MONDO_0007254","EFO_0001071","EFO_0005952","MONDO_0021063","MONDO_0001187","EFO_0000565","MONDO_0002158","EFO_0000588","MONDO_0002974","EFO_0000770","MONDO_0008903","EFO_0000389","EFO_0002918","EFO_0000183","EFO_0002617","EFO_1000158","EFO_0001416","EFO_0000616","MONDO_0001402","EFO_0005922","EFO_0000437","EFO_0000248","MONDO_0008170","EFO_0000403","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_0000621","EFO_0000311","EFO_0000211","EFO_1000026","EFO_0003032","EFO_0006861","EFO_0005537","MONDO_0011962","EFO_0004284","EFO_0000233","EFO_0000574","MONDO_0002367","EFO_0000702","EFO_0001378","MONDO_0002863","MONDO_0017386","EFO_1000895","MONDO_0024880","EFO_0000691","MONDO_0021637","EFO_0003050"],"count":55},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for cancer and neoplasm and has 53 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL565","canonicalSmiles":"CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1","inchiKey":"KNHUKKLJHYUCFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFIBRATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atromid","Atromid-s","Clofibrate"],"synonyms":["AY-61123","Chlorfenisate","Clofibrate","Ethyl p-chlorophenoxyisobutyrate","ICI 28257","ICI-28257","NSC-79389"],"crossReferences":{"PubChem":["11110971","119396","124879709","144203667","144209612","170465329","50106069","57260455","85230976","90341380"],"TG-GATEs":["6"],"Wikipedia":["Clofibrate"],"drugbank":["DB00636"],"chEBI":["3750"]},"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_1001375","EFO_0000319","EFO_0000612"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL589390","canonicalSmiles":"Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1","inchiKey":"JNODQFNWMXFMEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LATREPIRDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimebolin","Dimebon","Latrepirdine"],"crossReferences":{"PubChem":["104223880","85146210"],"drugbank":["DB11725"]},"childChemblIds":["CHEMBL1088975","CHEMBL2105703"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL592435","canonicalSmiles":"OC1CCC(Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1","inchiKey":"RBZNJGHIKXAKQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERENOFYLLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Derenofylline","SLV-320","SLV320","Slv320"],"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0000373"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL66","canonicalSmiles":"O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O","inchiKey":"CXQWRCVTCMQVQX-LSDHHAIUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-TAXIFOLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cianidanol"],"crossReferences":{"PubChem":["26719897","26719898","49681666","56463005"],"Wikipedia":["Taxifolin"],"drugbank":["DB02224"],"chEBI":["17948"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL74355","canonicalSmiles":"COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC","inchiKey":"HXTGXYRHXAGCFP-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOLINANSERIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["M-100907","M100907","MDL-100.907","MDL-100907","MDL100.907","Mdl-100907","Volinanserin"],"crossReferences":{"PubChem":["144210564"],"Wikipedia":["Volinanserin"]},"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0004698"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL744","canonicalSmiles":"Nc1nc2ccc(OC(F)(F)F)cc2s1","inchiKey":"FTALBRSUTCGOEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILUZOLE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exservan","Rilutek","Riluzole","Teglutik","Tiglutik kit"],"synonyms":["BHV-0223","NSC-753433","NSC-759823","RP 54274","RP-54274","Riluzole","Tiglutik"],"crossReferences":{"DailyMed":["riluzole"],"PubChem":["104171227","11111723","11113346","124881305","144203803","170464928","26751529","50104104","85231207","855844","90341557"],"Wikipedia":["Riluzole"],"drugbank":["DB00740"],"chEBI":["8863"]},"childChemblIds":["CHEMBL1531817"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0008525","EFO_0003756","Orphanet_98756","EFO_0000275","MONDO_0002009","EFO_1001919","MONDO_0007254","EFO_0001358","MONDO_0000437","Orphanet_908","EFO_1001050","EFO_0001072","Orphanet_94147","EFO_0000289","MONDO_0002050","Orphanet_683","Orphanet_399","MONDO_0005301","EFO_0000389","EFO_0004895","EFO_0003100","MONDO_0004975","HP_0002196","MONDO_0004976","EFO_0004242","MONDO_0024880","EFO_0008522"],"count":27},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for amyotrophic lateral sclerosis and has 21 investigational indications."}
{"id":"CHEMBL796","canonicalSmiles":"COC(=O)C(c1ccccc1)C1CCCCN1","inchiKey":"DUGOZIWVEXMGBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHYLPHENIDATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Concerta","Cotempla xr-odt","Daytrana"],"synonyms":["Concerta","Methylin","Methylphenidate","Methylphenidate extended release","Prc-063","Threo-dl-methylphenidate"],"crossReferences":{"DailyMed":["methylphenidate","methylphenidate%20hydrochloride"],"Wikipedia":["Methylphenidate"],"drugbank":["DB00422"],"chEBI":["84276"]},"childChemblIds":["CHEMBL1722"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0002610","MONDO_0002009","Orphanet_232","EFO_0004216","HP_0000726","EFO_0005252","EFO_0003768","EFO_0008568","EFO_0009267","HP_0100543","EFO_0000289","MONDO_0002050","MONDO_0045054","MONDO_0005180","EFO_0000712","EFO_0004701","EFO_0004242","HP_0012378","MONDO_0007079","EFO_0005230","Orphanet_797","EFO_0003888","EFO_0005203","HP_0012532","EFO_0007625","EFO_0001642","EFO_0005323","EFO_0003929","Orphanet_636","EFO_0001358","EFO_0010445","MONDO_0008315","EFO_0001663","EFO_0000311","Orphanet_209908","EFO_0003840","EFO_0003890","HP_0002045","MONDO_0005301","MONDO_0004975","EFO_0005611","MONDO_0016158","MONDO_0043510","EFO_0003833","MONDO_0024880"],"count":45},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for attention deficit hyperactivity disorder and narcolepsy-cataplexy syndrome and has 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL817","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1","inchiKey":"OUDSBRTVNLOZBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLAZAMIDE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tolazamide","Tolinase"],"synonyms":["NSC-70762","Tolazamide","U-17835"],"crossReferences":{"PubChem":["11111870","124881598","144203832","144208705","144210734","170465136","26747047","26751566","50104182","56422126","85231252","855941"],"Wikipedia":["Tolazamide"],"drugbank":["DB00839"],"chEBI":["9613"]},"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0000400","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and is indicated for type 2 diabetes mellitus and diabetes mellitus."}
{"id":"CHEMBL92870","canonicalSmiles":"Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"ZBIAKUMOEKILTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIDOFLAZINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Angex","Clinium"],"synonyms":["Lidoflazine","MCN-JR-7904","R 7904","R-7904"],"crossReferences":{"PubChem":["11112534","144204084","170466621","174006628","56463026"],"drugbank":["DB13766"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL98","canonicalSmiles":"O=C(CCCCCCC(=O)Nc1ccccc1)NO","inchiKey":"WAEXFXRVDQXREF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VORINOSTAT","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zolinza"],"synonyms":["MK-0683","MK0683","NSC-701852","NSC-748799","NSC-759852","Suberoylanilide hydroxamic acid","Vorinostat"],"crossReferences":{"DailyMed":["vorinostat"],"PubChem":["104171411","124893442","144206158","144207172","170465180","49645508","50113029"],"Wikipedia":["Vorinostat"],"drugbank":["DB02546"],"chEBI":["45716"]},"linkedTargets":{"rows":["ENSG00000094631","ENSG00000116478","ENSG00000171720","ENSG00000196591"],"count":4},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0003869","EFO_0004708","EFO_0000365","EFO_0000756","EFO_0000681","MONDO_0000956","EFO_1000657","EFO_0005952","EFO_1001110","EFO_1001951","EFO_0000565","EFO_0000309","MONDO_0015760","EFO_0000588","EFO_0000096","EFO_0000339","MONDO_0003268","MONDO_0019460","MONDO_0008903","EFO_0000330","EFO_0000641","MONDO_0015277","EFO_0003828","EFO_1000785","EFO_0000198","EFO_0002618","EFO_0003893","MONDO_0019465","EFO_0000220","MONDO_0008170","EFO_0000180","EFO_0000349","EFO_0002939","EFO_1001968","EFO_1000309","MONDO_0004986","EFO_0002429","MONDO_0008315","EFO_0000224","MONDO_0001879","EFO_0000384","EFO_1001967","EFO_1000026","Orphanet_398934","MONDO_0002691","MONDO_0044787","EFO_0000574","EFO_1001051","EFO_0001378","MONDO_0021640","MONDO_0005090","EFO_0002938","Orphanet_232","EFO_0002913","EFO_1001465","MONDO_0007254","EFO_1001469","MONDO_0021063","MONDO_0002087","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_1000044","EFO_1001380","EFO_0006352","EFO_0000770","EFO_1001830","MONDO_0001657","EFO_0000673","EFO_0002499","EFO_0000183","EFO_1000158","EFO_0000479","EFO_0000616","EFO_1000616","EFO_0005774","MONDO_0019457","EFO_0000403","MONDO_0007576","EFO_0000222","EFO_0004198","EFO_0002501","EFO_0007535","MONDO_0000870","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0006861","EFO_0000095","EFO_0000764","MONDO_0004975","EFO_0000702","EFO_0000191","MONDO_0018906","EFO_0003833","EFO_0000691","EFO_0000519","MONDO_0044926"],"count":100},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved and 84 investigational indications."}
